Montelukast
- Generic Name
- Montelukast
- Brand Names
- Singulair
- Drug Type
- Small Molecule
- Chemical Formula
- C35H36ClNO3S
- CAS Number
- 158966-92-8
- Unique Ingredient Identifier
- MHM278SD3E
- Background
Montelukast was first approved for clinical use by the US FDA in 1998 as Merck's brand name Singulair. The medication is a member of the leukotriene receptor antagonist (LTRA) category of drugs. Although capable of demonstrating effectiveness, the use of such LTRAs like montelukast is typically in addition to or complementary with the use of inhaled corticos...
- Indication
Montelukast is indicated for:
...
- Associated Conditions
- Asthma, Exercise-Induced Bronchospasm, Perennial Allergic Rhinitis (PAR), Seasonal Allergic Rhinitis
- Associated Therapies
- -
Bioequivalency Study of Montelukast 10 mg Tablets Under Fed Conditions
- First Posted Date
- 2012-08-08
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 35
- Registration Number
- NCT01659918
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fasted Conditions
- First Posted Date
- 2012-08-08
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 35
- Registration Number
- NCT01659905
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) Patients
- Conditions
- Interventions
- First Posted Date
- 2012-07-13
- Last Posted Date
- 2013-04-08
- Lead Sponsor
- Hanmi Pharmaceutical Company Limited
- Target Recruit Count
- 283
- Registration Number
- NCT01640535
- Locations
- 🇰🇷
Soonchunhyang University Bucheon Hospital, Bucheon, Gyeonggi-do, Korea, Republic of
Ventilatory Heterogeneity in Participants With Asthma (MK-0476-513)
- First Posted Date
- 2012-06-18
- Last Posted Date
- 2017-04-20
- Lead Sponsor
- Hal C Charles
- Target Recruit Count
- 34
- Registration Number
- NCT01621386
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Effects of Montelukast in Asthmatic Children With and Without Food Allergy
- First Posted Date
- 2012-06-13
- Last Posted Date
- 2017-08-14
- Lead Sponsor
- Hacettepe University
- Target Recruit Count
- 113
- Registration Number
- NCT01618929
- Locations
- 🇹🇷
Cansin Sackesen, Ankara, Turkey
Individualized Therapy For Asthma in Toddlers
- Conditions
- Interventions
- First Posted Date
- 2012-05-25
- Last Posted Date
- 2017-03-16
- Lead Sponsor
- Milton S. Hershey Medical Center
- Target Recruit Count
- 300
- Registration Number
- NCT01606306
- Locations
- 🇺🇸
St. Louis Children's Hospital, St. Louis, Missouri, United States
🇺🇸University of Wisconsin-Madison, Madison, Wisconsin, United States
🇺🇸University of Arizona College of Medicine, Tucson, Arizona, United States
A Placebo and Active Controlled Study of ONO-6950 Following Allergen Challenge in Patients With Asthma
- First Posted Date
- 2012-03-12
- Last Posted Date
- 2013-04-30
- Lead Sponsor
- Ono Pharma USA Inc
- Target Recruit Count
- 25
- Registration Number
- NCT01551147
- Locations
- 🇨🇦
Calgary Clinical Site 540, Alberta, Canada
🇨🇦Hamilton Clinical Site 550, Ontario, Canada
🇨🇦Saskatoon Clinical Site 520, Saskatoon, Canada
A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients
- First Posted Date
- 2012-02-20
- Last Posted Date
- 2014-02-14
- Lead Sponsor
- Ono Pharma USA Inc
- Target Recruit Count
- 59
- Registration Number
- NCT01536041
- Locations
- 🇺🇸
Raleigh Clinical Site 130, Raleigh, North Carolina, United States
🇺🇸Denver Clinical Site 160, Denver, Colorado, United States
🇺🇸San Diego Clinical Site 140, San Diego, California, United States
Management of Asthma in School-age Children on Therapy
- Conditions
- Interventions
- First Posted Date
- 2012-02-03
- Last Posted Date
- 2012-02-03
- Lead Sponsor
- Professor Warren Lenney
- Target Recruit Count
- 229
- Registration Number
- NCT01526161
A Trial of Montelukast for Maintenance Therapy of Eosinophilic Esophagitis in Children
- Conditions
- Interventions
- First Posted Date
- 2011-10-24
- Last Posted Date
- 2020-10-30
- Lead Sponsor
- Children's Mercy Hospital Kansas City
- Target Recruit Count
- 4
- Registration Number
- NCT01458418
- Locations
- 🇺🇸
Children's Mercy Hospitals and Clinics, Kansas City, Missouri, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.